Phase 4 Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People who have been diagnosed with either ocular hypertension (higher-than-normal eye pressure) or open-angle glaucoma (a common type of glaucoma)
- People who have had an eye examination within the past year
- For those with glaucoma: test results showing changes to the optic nerve or surrounding nerve layer, as well as changes in the field of vision, that are consistent with glaucoma
- People whose best vision (with glasses or contacts if needed) is at least 20/100
- People whose eye drainage angle (the part of the eye that controls fluid outflow) is confirmed to be open, based on two specific eye tests
- People whose eye pressure falls between 18 and 34 mmHg, either without any prior treatment or after stopping previous eye pressure medications for a set period
Who may not be able to join:
- People who are known to have had a bad reaction or intolerance to a medicine called netarsudil eye drops
- People who have scarring on the cornea (the clear front surface of the eye) or an active corneal condition that would interfere with eye imaging
- People who are unable to tolerate the eye examination procedure called gonioscopy
- Women who are able to become pregnant and are not using effective contraception or have not been surgically sterilised
- People who have any other condition that the trial doctor believes could put them at greater risk or prevent them from completing the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (812) 855-1344
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Trabecular Meshwork Lamellae Spacing
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.